|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
12/16/20 Rajah Vignesh 4 Officer² 1:5K Y-mAbs Therapeutics, Inc. Toppan Merrill/FA
12/16/20 Lund-Hansen Torben 4 Officer² 1:5K Y-mAbs Therapeutics, Inc. Toppan Merrill/FA
12/16/20 Kruse Bo 4 Officer² 1:5K Y-mAbs Therapeutics, Inc. Toppan Merrill/FA
12/16/20 Lisby Steen 4 Officer² 1:5K Y-mAbs Therapeutics, Inc. Toppan Merrill/FA
12/16/20 Moller-San Pedro Claus Juan 4 Dir.,Off.² 1:5K Y-mAbs Therapeutics, Inc. Toppan Merrill/FA
12/16/20 Gad Thomas 4 Dir.,Off.² 1:5K Y-mAbs Therapeutics, Inc. Toppan Merrill/FA
12/16/20 Herman Philip Karl 4 Officer² 1:5K Y-mAbs Therapeutics, Inc. Toppan Merrill/FA
12/16/20 Wilms Joris 4 Officer² 1:5K Y-mAbs Therapeutics, Inc. Toppan Merrill/FA
____________ | ¹ | Filing/Form Type: | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|